Effects of a Novel Platelet Nitric Oxide Donor (LA816), Aspirin, Clopidogrel, and Combined Therapy in Inhibiting Flow- And Lesion-Dependent Thrombosis in the Porcine Ex Vivo Model
Circulation - United States
doi 10.1161/01.cir.0000142296.19558.99
Full Text
Open PDFAbstract
Available in full text
Date
September 21, 2004
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)